Key facts
as of Sep 2026- It has raised $12.4M; the latest was Seed Round ($10.0M) in Apr 2026.
- Notable investors include BoxGroup, Gradient Ventures, Redalpine, Fit 4 Start, Clément Delangue — 11 tracked in total.
- 2 institutional filers report fund marks on Helical across 5 filings.
- Status: Privately Held (backing).
- ·The complete investor list — 11 names
- ·Watchlist + deal alerts for Helical
- ·The full record, as it builds
Recorded secondary trades
No secondary trades in Helical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
2 filers · latest Jan 20262 SEC-registered funds reported 5 fair-value marks on Helical between Apr 2025 and Jan 2026. Filer-level marks and implied $/share are available to Pro members.
Funding rounds
No funding rounds for Helical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Helical
Developer of an open-source platform designed to integrate DNA and RNA models for drug discovery. The company offers model libraries and bio AI agents with easy API interfaces, transparent model evaluation, and customizable extensions to proprietary data, enabling pharmaceutical and biotech companies to integrate and build drug discovery applications seamlessly.
- Sector
- Healthcare
- HQ
- Gare, Luxembourg
- Founded
- 2023
- Employees
- 21
- Website
- helical.bio/
- Ownership
- Privately Held (backing)